Methods for treating cardiovascular disease using a soluble CTLA4 molecule

Details for Australian Patent Application No. 2009243460 (hide)

Owner Bristol-Myers Squibb Company

Inventors Rusnak, James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009243460

Parent 2004264901

Filing date 1 December 2009

Wipo publication date 24 December 2009

Acceptance publication date 1 March 2012

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

17 December 2009 Complete Application Filed

24 December 2009 Application Open to Public Inspection

  Published as AU-B-2009243460

1 March 2012 Application Accepted

  Published as AU-B-2009243460

28 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009243461-Soil nail launcher

2009243459-Electrical isolation of a driveline system via a non-conductive interface on a driveshaft assembly